Cart
sales@molnova.com
hVEGF-IN-1
CAS No. 1637443-98-1
hVEGF-IN-1 ( —— )
Catalog No. M17352 CAS No. 1637443-98-1
hVEGF-IN-1 inhibits human VEGF-A translation and has antitumor activity.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 200 | In Stock |
|
| 10MG | 282 | In Stock |
|
| 25MG | 476 | In Stock |
|
| 50MG | 689 | In Stock |
|
| 100MG | 963 | In Stock |
|
| 500MG | 1935 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamehVEGF-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionhVEGF-IN-1 inhibits human VEGF-A translation and has antitumor activity.
-
DescriptionhVEGF-IN-1 inhibits human VEGF-A translation and has antitumor activity.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorVEGF-A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1637443-98-1
-
Formula Weight581.75
-
Molecular FormulaC34H43N7O2
-
Purity98%
-
SolubilityDMSO : 25 mg/mL42.97 mM;H2O : < 0.1 mg/mL
-
SMILESCCN(CC)CCOc1ccc(cc1)Nc1nc(c2c(NC(=O)CCN3CCN(C)CC3)cccc2)nc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Discovery of Small Molecules for Repressing Cap-Independent Translation of Human VascularEndothelial Growth Factor (hVEGF) as Novel Antitumor Agents. J Med Chem. 2017 Jul 13;60(13):5306-5319.
molnova catalog
related products
-
Procaterol hydrochlo...
Short-acting β2-adrenergic receptor agonist used to treat asthma.
-
Chrysosptertin B
Chrysosplenetin is a metabolic inhibitor of artemisinin.
-
AmmTX3
KV4 channel blocker. Blocks A-type K+ current (ISA) in mouse cerebellar granule neurons. The accessory dipeptidyl peptidase-like proteins (DPP) 6 and 10 are required for blockade.
